Lilly ICOS LLC Release: Cialis Filed In European Union For Once-A-Day Dosing For Erectile Dysfunction

Published: Jun 08, 2006

BOTHELL, Wash.--(BUSINESS WIRE)--June 7, 2006--ICOS Corporation (Nasdaq:ICOS - News) today announced that Lilly ICOS LLC, its joint venture with Eli Lilly and Company (NYSE:LLY - News), has submitted a regulatory filing for marketing approval to the European Medicines Agency (EMEA) for CialisĀ® (tadalafil) 2.5 mg and 5 mg once-a-day dosing to treat erectile dysfunction (ED). Lilly ICOS plans to file in the United States and Canada later in 2006. If approved, the first launches could occur in late 2007.

Back to news